David Rescott

Q: What is David Rescott's success rate?

David Rescott currently has a success rate of 84.97219981159635.

Q: What is the average return of David Rescott's calls?

Their stock ratings have generated an average return of 13.91321905254718.

Baird | Healthcare

David Rescott is an analyst from Baird specializing in the Healthcare sector. Ranked #1712 out of 4565 analysts, they have issued 18 stock ratings with a success rate of 84.97% and an average return of 13.91%.

With 18 ratings to date, David Rescott is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 84.97% and an average return of 13.91%, highlighting promising potential as their track record develops further.

#1712

Out of 4565

Total Ratings

+84.97%

Success Rate

+13.91%

Average Return

Recent Ratings Analysis

PRCT

Hold

Mar 06, 2026

Target

$30.00

Current

$24.22

Performance

0.00%

David Rescott rated PRCT as Neutral on Mar 06, 2026, setting a price target of 30. The Hold stance appears justified, as shares hovered around 24.22 with a 0.00% move.

MDT

Hold

Feb 18, 2026

Target

$103.00

Current

$90.90

Performance

-7.71%

On Feb 18, 2026, MDT was given a Neutral rating by David Rescott, with a target price of 103. The rating provided protection from downside risk as the stock fell to 90.9.

BSX

Buy

Feb 05, 2026

Target

$101.00

Current

$71.35

Performance

-8.10%

BSX received a Outperform rating from David Rescott on Feb 05, 2026, aiming for 101. The rating hasn’t played out as hoped, with the stock trading 8.10% below expectations.

PEN

Hold

Jan 16, 2026

Target

$374.00

Current

$338.64

Performance

-3.46%

On Jan 16, 2026, David Rescott published a Neutral outlook on PEN, with a target of 374. Sideways action left the Hold view intact, with no major move since 338.64.

SIBN

Buy

Dec 18, 2025

Target

$23.00

Current

$13.83

Performance

David Rescott on Dec 18, 2025 assigned SIBN a Buy rating, with a price target of 23. The recommendation remains pending validation as shares consolidate around 13.83.

EW

Hold

Dec 16, 2025

Target

$88.00

Current

$81.64

Performance

-4.31%

On Dec 16, 2025, David Rescott reaffirmed EW with a Neutral rating, targeting 88. The neutral call matched muted market action of -4.31%.

HAE

Buy

Dec 15, 2025

Target

$99.00

Current

$64.13

Performance

-20.24%

HAE was rated Outperform by David Rescott on Dec 15, 2025, with a price objective of 99. This case shows how bullish projections can fail, with the stock now below 64.13.

LIVN

Buy

Nov 13, 2025

Target

$70.00

Current

$63.84

Performance

15.65%

On Nov 13, 2025, David Rescott initiated coverage on LIVN with a Outperform rating and target of 70. The stock’s climb of 15.65% since the call highlights the foresight in the rating.

ISRG

Buy

Mar 18, 2025

Target

$600.00

Current

$490.16

Performance

1.28%

David Rescott issued a Outperform recommendation for ISRG on Mar 18, 2025, price target set at 600. The target of 600 remains in play, though confirmation will depend on future moves.

NARI

Hold

Jan 07, 2025

Target

$80.00

Current

$79.97

Performance

0.65%

On Jan 07, 2025, NARI was evaluated by David Rescott, who gave a Neutral rating and target of 80. Hold sentiment was validated by subdued trading with no breakout beyond 79.97.

IRTC

Buy

Jul 16, 2024

Target

$134.00

Current

$123.59

Performance

17.75%

David Rescott rated IRTC as Buy on Jul 16, 2024, setting a price target of 134. The call has proven timely, with shares rising 17.75% toward the price target of 134.

MMSI

Buy

Jun 28, 2024

Target

$96.00

Current

$72.66

Performance

-15.46%

On Jun 28, 2024, MMSI was given a Outperform rating by David Rescott, with a target price of 96. Despite the Buy call, shares fell from 72.66 to 72.66, challenging the optimistic stance.

Frequency Asked Questions

Who is David Rescott?

David Rescott is an analyst from Baird specializing in the Healthcare sector.

What is David Rescott's success rate?

David Rescott currently has a success rate of +84.97%.

How many ratings has David Rescott issued?

David Rescott has issued 18 stock ratings so far.

What is the average return of David Rescott's calls?

Their stock ratings have generated an average return of +13.91%.

What is David Rescott's ranking?

David Rescott is ranked #1712 out of 4565 analysts.

What types of ratings does David Rescott give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Rescott?

You can follow David Rescott by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Rescott?

Their latest rating was a Hold on PRCT issued on 2026-03-06.